We are live on ! Find out more
NA

Navellier & Associates Portfolio holdings

AUM $1.26B
1-Year Est. Return 95.39%
This Fund
S&P 500
This Quarter Est. Return
+15.72%
1 Year Est. Return
+95.39%
3 Year Est. Return
+360.87%
5 Year Est. Return
+519.82%
10 Year Est. Return
+3,025.56%
AUM
$458M
AUM Growth
+$37.6M
Cap. Flow
-$6.72M
Cap. Flow %
-1.47%
Top 10 Hldgs %
23.87%
Holding
273
New
42
Increased
69
Reduced
91
Closed
46

Sector Composition

Rank Sector Weight
1 Technology 32.98%
2 Healthcare 16.35%
3 Industrials 9.79%
4 Consumer Discretionary 8.39%
5 Consumer Staples 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKC icon
251
McCormick & Company Non-Voting
MKC
$14.1B
-4,220
Closed -$379K
MRCY icon
252
Mercury Systems
MRCY
$6.53B
-3,484
Closed -$274K
NAT icon
253
Nordic American Tanker
NAT
$1.36B
-73,205
Closed -$297K
NEWT icon
254
NewtekOne
NEWT
$432M
-28,006
Closed -$510K
NHI icon
255
National Health Investors
NHI
$3.65B
-6,807
Closed -$413K
POWI icon
256
Power Integrations
POWI
$3.29B
-8,092
Closed -$478K
PWR icon
257
Quanta Services
PWR
$100B
-5,852
Closed -$230K
ROKU icon
258
Roku
ROKU
$22.3B
-2,215
Closed -$258K
SSO icon
259
ProShares Ultra S&P500
SSO
$8.26B
-31,744
Closed -$496K
TECH icon
260
Bio-Techne
TECH
$11.2B
-6,964
Closed -$460K
TNK icon
261
Teekay Tankers
TNK
$2.67B
-12,583
Closed -$161K
TRU icon
262
TransUnion
TRU
$15.2B
-67,393
Closed -$5.87M
TTEC icon
263
TTEC Holdings
TTEC
$127M
-8,464
Closed -$394K
VEU icon
264
Vanguard FTSE All-World ex-US ETF
VEU
$67.8B
-4,232
Closed -$201K
VRSN icon
265
VeriSign
VRSN
$26.4B
-1,330
Closed -$275K
VXX icon
266
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$146M
-126
Closed -$274K
ZYXI
267
DELISTED
Zynex
ZYXI
-22,122
Closed -$500K
RCM
268
DELISTED
R1 RCM Inc. Common Stock
RCM
-20,017
Closed -$223K
PRFT
269
DELISTED
Perficient Inc
PRFT
-9,442
Closed -$338K
MLNX
270
DELISTED
Mellanox Technologies, Ltd.
MLNX
-2,392
Closed -$299K
BDSI
271
DELISTED
BioDelivery Sciences International, Inc.
BDSI
-40,168
Closed -$175K
SVA
272
DELISTED
Sinovac Biotech, Ltd
SVA
$0 ﹤0.01%
22,786
-601
-3%

Similar funds

Navellier & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Navellier & Associates held 273 positions worth $458M, up 8.9% from $421M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Navellier & Associates's Q3 2020 filing shows 42 new, 69 increased, 91 reduced and 46 closed positions. Its largest new stake was Rollins: 188,696 shares worth $6.82M. The largest sale was First Trust Financials AlphaDEX Fund, an estimated $6.46M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

  • Navellier & Associates's largest Q3 2020 buy was Rollins: 188,696 shares worth $6.82M.
  • Navellier & Associates added most to Monolithic Power Systems in Q3 2020, an estimated $6.76M increase.
  • Navellier & Associates's biggest Q3 2020 reduction was Clorox, cutting an estimated $6.09M.
  • Navellier & Associates fully exited First Trust Financials AlphaDEX Fund in Q3 2020, selling an estimated $6.46M.
  • Navellier & Associates's ten largest holdings make up 24% of its $458M portfolio in Q3 2020.
  • Navellier & Associates opened 42 new positions and closed 46 in Q3 2020.
  • Navellier & Associates's portfolio value rose 8.9% quarter-over-quarter to $458M.

Based on Navellier & Associates's 13F filing for Q3 2020, filed 9 Nov 2020.